BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 38436957)

  • 1. MACE and Hyperthyroidism Treated With Medication, Radioactive Iodine, or Thyroidectomy.
    Peng CC; Lin YJ; Lee SY; Lin SM; Han C; Loh CH; Huang HK; Pearce EN
    JAMA Netw Open; 2024 Mar; 7(3):e240904. PubMed ID: 38436957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Radioactive Iodine, Antithyroid Drug, and Surgical Treatments With Solid Cancer Mortality in Patients With Hyperthyroidism.
    Kitahara CM; Preston DL; Sosa JA; Berrington de Gonzalez A
    JAMA Netw Open; 2020 Jul; 3(7):e209660. PubMed ID: 32701159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative Effectiveness of Treatment Choices for Graves' Hyperthyroidism: A Historical Cohort Study.
    Sundaresh V; Brito JP; Thapa P; Bahn RS; Stan MN
    Thyroid; 2017 Apr; 27(4):497-505. PubMed ID: 28049375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of Graves' Disease Patients Following Antithyroid Drugs, Radioactive Iodine, or Thyroidectomy as the First-line Treatment.
    Liu X; Wong CKH; Chan WWL; Tang EHM; Woo YC; Lam CLK; Lang BHH
    Ann Surg; 2021 Jun; 273(6):1197-1206. PubMed ID: 33914484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular Morbidity and Mortality After Treatment of Hyperthyroidism with Either Radioactive Iodine or Thyroidectomy.
    Ryödi E; Metso S; Huhtala H; Välimäki M; Auvinen A; Jaatinen P
    Thyroid; 2018 Sep; 28(9):1111-1120. PubMed ID: 29882483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of Use, Efficacy, and Safety of Treatment Options for Patients with Graves' Disease: A Nationwide Population-Based Study.
    Brito JP; Payne S; Singh Ospina N; Rodriguez-Gutierrez R; Maraka S; Sangaralingham LR; Iñiguez-Ariza NM; Montori VM; Stan MN
    Thyroid; 2020 Mar; 30(3):357-364. PubMed ID: 31973681
    [No Abstract]   [Full Text] [Related]  

  • 7. A comparison of cardiovascular disease, cancer, mortality, and Graves' ophthalmopathy following treatment for hyperthyroidism: A Bayesian network meta-analysis.
    Liu X; Wong CKH; Wu T; Chan WWL; Woo YC; Lam CLK; Lang BHH
    World J Surg; 2024 Feb; 48(2):393-407. PubMed ID: 38686801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment Modality and Risk of Heart Failure in Patients With Long-Standing Graves' Disease: A Nationwide Population-Based Cohort Study.
    Song E; Kim M; Park S; Park MJ; Kim JA; Roh E; Yu JH; Kim NH; Seo JA; Kim SG; Kim NH; Choi KM; Baik SH; Yoo HJ
    Front Endocrinol (Lausanne); 2021; 12():761782. PubMed ID: 34690936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired Quality of Life After Radioiodine Therapy Compared to Antithyroid Drugs or Surgical Treatment for Graves' Hyperthyroidism: A Long-Term Follow-Up with the Thyroid-Related Patient-Reported Outcome Questionnaire and 36-Item Short Form Health Status Survey.
    Törring O; Watt T; Sjölin G; Byström K; Abraham-Nordling M; Calissendorff J; Cramon PK; Filipsson Nyström H; Hallengren B; Holmberg M; Khamisi S; Lantz M; Wallin G
    Thyroid; 2019 Mar; 29(3):322-331. PubMed ID: 30667296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer Risk After Radioactive Iodine Treatment for Hyperthyroidism: A Systematic Review and Meta-analysis.
    Shim SR; Kitahara CM; Cha ES; Kim SJ; Bang YJ; Lee WJ
    JAMA Netw Open; 2021 Sep; 4(9):e2125072. PubMed ID: 34533571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary therapy of Graves' disease and cardiovascular morbidity and mortality: a linked-record cohort study.
    Okosieme OE; Taylor PN; Evans C; Thayer D; Chai A; Khan I; Draman MS; Tennant B; Geen J; Sayers A; French R; Lazarus JH; Premawardhana LD; Dayan CM
    Lancet Diabetes Endocrinol; 2019 Apr; 7(4):278-287. PubMed ID: 30827829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effectiveness of therapies for Graves' hyperthyroidism: a systematic review and network meta-analysis.
    Sundaresh V; Brito JP; Wang Z; Prokop LJ; Stan MN; Murad MH; Bahn RS
    J Clin Endocrinol Metab; 2013 Sep; 98(9):3671-7. PubMed ID: 23824415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perioperative Management and Outcomes of Hyperthyroid Patients Unable to Tolerate Antithyroid Drugs.
    Hsieh LB; Yen TWF; Dream S; Patel D; Evans DB; Wang TS
    World J Surg; 2020 Nov; 44(11):3770-3777. PubMed ID: 32572525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in Thyrotropin Receptor Antibody Levels Following Total Thyroidectomy or Radioiodine Therapy in Patients with Refractory Graves' Disease.
    Kim J; Choi MS; Park J; Park H; Jang HW; Choe JH; Kim JH; Kim JS; Cho YS; Choi JY; Kim TH; Chung JH; Kim SW
    Thyroid; 2021 Aug; 31(8):1264-1271. PubMed ID: 33947272
    [No Abstract]   [Full Text] [Related]  

  • 15. THE TRENDS OF HYPERTHYROIDISM TREATMENT IN TAIWAN: A NATIONWIDE POPULATION-BASED STUDY.
    Kornelius E; Yang YS; Huang CN; Wang YH; Lo SC; Lai YR; Chiou JY
    Endocr Pract; 2018 Jun; 24(6):573-579. PubMed ID: 29688762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Definitive treatment of Graves' disease in children and adolescents.
    Król A; Czarniecka A; Jarząb B
    Endokrynol Pol; 2021; 72(6):661-665. PubMed ID: 34855196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of cold iodine in patients with Graves' disease: observations from a clinical practice.
    Hao ST; Reasner CA; Becker RA
    Endocr Pract; 2001; 7(6):438-42. PubMed ID: 11747279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of β-blocker therapy with risks of adverse cardiovascular events and deaths in patients with ischemic heart disease undergoing noncardiac surgery: a Danish nationwide cohort study.
    Andersson C; Mérie C; Jørgensen M; Gislason GH; Torp-Pedersen C; Overgaard C; Køber L; Jensen PF; Hlatky MA
    JAMA Intern Med; 2014 Mar; 174(3):336-44. PubMed ID: 24247428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of lithium on efficacy of radioactive iodine therapy for Graves' disease: a cohort study on cure rate, time to cure, and frequency of increased serum thyroxine after antithyroid drug withdrawal.
    Bogazzi F; Giovannetti C; Fessehatsion R; Tanda ML; Campomori A; Compri E; Rossi G; Ceccarelli C; Vitti P; Pinchera A; Bartalena L; Martino E
    J Clin Endocrinol Metab; 2010 Jan; 95(1):201-8. PubMed ID: 19906789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer Incidence and Mortality in Patients Treated Either With RAI or Thyroidectomy for Hyperthyroidism.
    Ryödi E; Metso S; Jaatinen P; Huhtala H; Saaristo R; Välimäki M; Auvinen A
    J Clin Endocrinol Metab; 2015 Oct; 100(10):3710-7. PubMed ID: 26262435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.